Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration's review memo on Leqembi raised expectations for full approval of the Alzheimer's drug.
Source: MarketWatch
08. June 2023 04:00
Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration's review memo on Leqembi raised expectations for full approval of the Alzheimer's drug.
Source: MarketWatch